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Congenital heart defects (CHD) account for nearly one-third of all major congenital anomalies. Reported birth prevalence of CHD is 8 per 1000; although, it varies 
widely among the studies worldwide [1,2]. Critical CHD (CCHD) 
is a potentially life-threatening cardiac abnormality, which means 
that either the systemic or the pulmonary circulation, is dependent 
on the patent ductus arteriosus and it often requires invasive 
procedures in the first 28 days of life [3,4]. CCHD occurs at a 
frequency of 1.2-1.7 per 1000 live births and accounts for 10-15% 
of all cases of CHD [5]. Early diagnosis of CCHD is an important 
since the risk of morbidity and mortality increases when there is a 
delay in the diagnosis and referral to a tertiary center with expertise 
to treat such cases [6,7]. The previous research has shown that 
delay in identifying critical congenital disease increases mortality 
and may also increase morbidity post operatively [8,9].
Traditionally screening for CHDs included clinical assessment 
of pulses, heart sounds, and presence of cyanosis. However, 
clinical assessment alone has a fairly low detection rate, and a 
substantial number of babies are discharged from the hospital 
before CHDs are diagnosed [10]. This deficiency in detection is 
because of limitations in physical examination, such as difficulty 
in identifying cyanosis, especially in anemic or dark-pigmented 
neonates, early hospital discharge in duct-dependent lesions 
if the duct has not yet closed, and lack of murmurs in infants 
with CCHD. Prenatal USG at 18 weeks of gestation can detect 
many major congenital cardiac malformations. However, prenatal 
detection of CHD is only 57%, and isolated defects are detected 
even less frequently [11-13].
In the last 10-15 years, noninvasive transcutaneous pulse 
oximetry has provided the means and impetus for blood oxygen 
saturation screening as an adjunct to traditional screening 
methods. Pulse oximetry screening can identify newborns with 
CCHD who are missed by routine prenatal ultrasound and by 
predischarge examination [14,15]. Pulse oximetry is easily 
available and screening after 24 h of life can lead to the detection 
of CCHD during a critical period when potentially life-saving 
intervention can be undertaken. Numerous studies have shown 
that routine pulse oximetry is highly sensitive and specific for 
identifying CCHD [16-18]. Although pulse oximetry is a good 
tool for screening CCHDs with hypoxemia, its sensitivity for 
detection of left heart obstructive disease (LHOD) is low. Pulse 
oximetry-derived peripheral perfusion index (PPI) has been 
proposed as a tool to detect critical left heart obstruction but has 
never been studied prospectively [19]. Further studies of infants 
with various cardiac lesions are needed before incorporating PPI 
in the screening process for CCHD.
In 2011, the American Academy of Pediatrics and the American 
Heart Association recommended screening all asymptomatic 
babies with pulse oximetry to detect CCHD [20]. However, 
routine pulse oximetry screening for CCHD is not widely used 
in India, and there are only a few studies for the same. In the 
studies conducted in India, some have shown good sensitivity 
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and specificity, while others have not shown the same [21,22]. 
We undertook this study to find out the feasibility, utility and 
diagnostic accuracy of screening for CCHD with a new generation 
pulse oximeter in neonates delivered in a public hospital in India.
MATERIALS AND METHODS
The study was conducted in the postnatal ward of a tertiary hospital 
in Mumbai. This was a single center prospective observational 
study. All term neonates (>37 weeks) admitted to the postnatal 
ward were included in the study. Infants with multiple congenital 
malformations and antenatally diagnosed CHD were excluded. 
Infants were recruited over a period of 3 months from September 
2015 to November 2015. Informed consent was obtained before 
enrolment in the study. The study was cleared by the Hospital 
Ethics Committee.
Pulse oximeter saturation of all infants included in the study 
was recorded between 24 and 48 h of life by applying pulse 
oximeter probe on preductal (right palm) and postductal (any 
foot) site by the investigator while clinical examination was done 
by the registrar in the postnatal ward. The Masimo model radical 
7 pulse oximeter was used to document the saturations. Results 
were said to be positive if SpO2 saturation on pulse oximeter was 
<90% in right hand or foot. If SpO2 was 90% to <95% or there 
was >3% difference between right hand and foot, 3 readings were 
taken 1 h apart before labeling it positive [23].
Results were said to be negative if SpO2 saturation on pulse 
oximeter was ≥95% in right hand or foot and the difference 
between right hand and foot was ≤3% [23]. The PPI was noted 
for all the babies in either foot. The algorithm for pulse oximetry 
screening has been shown in Fig. 1. The diagnostic accuracy 
of pulse oximetry was measured by computation of sensitivity, 
specificity, positive and negative predictive values. If as per 
protocol the screen was positive, then the baby was evaluated 
further by chest X-ray, electrocardiogram and two-dimensional 
echocardiography (2D ECHO). ECHO was performed by a 
cardiologist who was blinded about the pulse oximetry results.
RESULTS
During our study period, there were total 2006 live births and 
1652 term live births. 1594 term newborns were screened by 
pulse oximetry. Fig. 2 shows the flow chart of screening. Nine 
infants with CHD were diagnosed on prenatal ultrasound scan. 
Table 1 shows the diagnosis of antenatally detected CHDs. Of 
the 1594 babies screened, 1589 (99.69%) neonates passed the 
screening and 5 failed the test. A total of 9 newborns (including 5 
on antenatal USG and 4 from postnatal pulse oximeter screening) 
had CCHDs, with incidence of 4.4 per 1000 live births. Seven 
neonates had a false negative test as they were subsequently 
diagnosed by clinical examination and 2D ECHO to have heart 
disease. Out of these babies, 2 babies were diagnosed to have 
small patent foramen ovale with patent ductus arteriosus (PDA), 
1 baby had a small atrial septal defect (ASD) with PDA, 3 babies 
had small to moderate ASD while one had tiny ASD with VSD.
Five neonates (0.31%) who failed the screening test had 
positive findings on clinical examination. Out of these babies, 
4 were diagnosed on 2D ECHO to have critical heart disease, which 
are shown in Table 2. One baby, who failed the screening test, had 
absent bilateral femoral pulsations on clinical examination and 
oxygen saturation could not be recorded in the lower limb. This 
baby died before a 2D ECHO could be done, and postmortem 
examination revealed interrupted aortic arch.
Sensitivity of pulse oximetry for CHDs was found to be 
41.67% (95% confidence interval [CI] 15.17-72.33%) with 
specificity of 100% (95% CI 99.77-100%). Positive predictive 
value was 100% (95% CI 47.82-100%) and negative predictive 
value was 99.56% (95% CI 99.09-99.82%). Negative likelihood 
ratio was 0.58 (95% CI 0.36-0.94). For CCHD, sensitivity was 
found to be 100% (95% CI 39.76-100%), with specificity of 
99.94% (95% CI 99.65-100%) and positive predictive value of 
80% (95% CI 28.36-99.49%), with negative predictive value 
of 100% (95% CI 99.77-100%). Positive likelihood ratio was 
1590 (95% CI 224.10-11280.97) and negative likelihood ratio 
was 0.
PPI ranged from 1.2 to 3.6 with a mean of 2.04 in infants who 
passed the test. In cases of failed test, they ranged from 0.8 to 0.9 
with mean a of 0.65. In the infant with IAA, no PPI values could 
be recorded at postductal site.
DISCUSSION
Out of the 1652 live births, 21 babies were diagnosed to have 
CHDs, with incidence of 10.4 per 1000 live births. Nine newborns 
had CCHDs, with incidence of 4.4 per 1000 live births, which 
is about twice the reported incidence. Out of these 9 babies, 
5 were diagnosed on antenatal scan while remaining 4 failed 
pulse oximetry screening and were subsequently diagnosed on 
2D ECHO and postmortem examination. Sensitivity was 41% 
for all CHD and 100% for CCHD. Specificity was 99.94% and 
false-positive rate of 0.06%.
In 2011, Ewer et al. reported the results of a prospective 
assessment of the accuracy of pulse oximetry as a tool for screening 
Table 1: Spectrum of congenital heart diseases in newborns who 
were diagnosed on antenatal scan
S. No. Congenital heart disease
1 Left hypoplastic heart with moderate ASD with large PDA
2 Left hypoplastic heart type A, large PDA, large ASD with 
hypoplastic aorta
3 d-TGA with VSD
4 Congenital heart block with VSD and PDA
5 Intracardiac TAPVC
6 Complete congenital heart block with VSD
7 OS ASD with bicuspid aortic valve
8 Dysplastic tricuspid valve
9 Tricuspid atresia
TGA: Transposition of great arteries, PDA: Patent ductus arteriosus, ASD: Atrial 
septal defect, VSD: Ventricular septal defect, OS: Ostium secundum, TAPVC: Total 
anomalous pulmonary venous connection
Vol 4 | Issue 2 | Apr - Jun 2017 Indian J Child Health 218
Palve et al. Pulse oximetry screening for CCHD - in India
for CCHD in 2005 neonates of >34 weeks’ gestational age. The 
study group here was quite large as compared to 1594 babies in 
our study. Major CHD was found in 53 neonates and CCHD in 24. 
Sensitivity was 58% for critical cases and 29% for all major heart 
disease which was less as compared to the sensitivity of 41% for 
all CHDs and 100% for CCHD in our study [16]. False-positive 
results were seen in 0.8% of newborn babies in this study, as 
compared to 0.06% for CCHD in our study.
Qu-ming Zhao et al. in a prospective multicenter study 
screened 122,738 consecutive newborn babies and detected 
CHDs in 1071. In babies screened for CCHD with pulse 
oximetry alone, sensitivity was 78.4%, specificity 99%, and 
false-positive rate was 0.29%. In addition of pulse oximetry to 
clinical assessment improved sensitivity for detection of CCHD 
from 77.4% (95% CI 70.0-83.4) to 93.2% (87.9-96.2) [24]. 
Compared to this, we had a sensitivity of 100%, specificity of 
99.94% and a false-positive rate of 0.06% in our study. Taksande 
et al. in a similar study in a hospital in rural India screened 2110 
asymptomatic neonates for CCHDs and found 100% sensitivity, 
99.95% specificity, 87.50% positive predictive value, and 100% 
Figure 1: Critical congenital heart defect screening algorithm [23] (percentages refer to oxygen saturation as measured by pulse oximeter)
Table 2: Clinical features and 2D ECHO findings of neonates who failed pulse oximetry screening
S. No. CVS examination Screening pass/fail 2D ECHO findings Postmortem 
finding
1 Cyanosis, tachypnea, PSM Failed D-TGA with intact IVS with large non-restricted PDA 
with large ASD with left to right shunt
2 PSM Failed Tricuspid atresia type IB with large OS ASD with R to L 
shunt, 3 mm subaortic VSD with L to R shunt 
3 PSM Failed PDA 2.5 mm restrictive, L to R shunt
4 Cyanosis, tachypnea Failed Supracardiac TAPVR
5 Absent bilateral femoral pulsations Failed IAA
PSM: Pan systolic murmur, TGA: Transposition of great arteries, IVS: Interventricular septum, PDA: Patent ductus arteriosus, ASD: Atrial septal defect, VSD: Ventricular septal 
defect, TAPVR: Total anomalous pulmonary venous return, IAA: Interrupted aortic arch, 2D ECHO: Two-dimensional echocardiography, CVS: Cardiovascular, OS: Ostium 
secundum
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negative predictive value [21]. This compares very well with our 
results.
Thangratinam et al. in a systematic review and meta-analysis 
screened 552 studies and identified 13 eligible studies with data 
for 229,421 newborn babies. The overall sensitivity of pulse 
oximetry for detection of CCHDs was 76.5% (95% CI 67.7-83.5). 
The specificity was 99.9% (99.7-99.9), with a false-positive rate 
of 0.14% (0.06-0.33). The false-positive rate for detection of 
CCHDs was particularly low when newborn pulse oximetry was 
done after 24 h from birth than when it was done before 24 h 
(0.05% [0.02-0.12] vs. 0.50 [0.29-0.86]; p=0.0017) [25].
In our study, all the 5 infants who failed the pulse oximeter 
screening also had signs suggestive of cardiac disorder in the form 
of pansystolic murmur, cyanosis, and absent pulses. Schena et al. 
studied 50244 infants and found that in tertiary hospitals, 95% 
of CHDs were identified before pulse oximeter screening either 
antenatally or on clinical examination. However, in 1-2 level 
units, only 28% were detected clinically, and perfusion index 
and pulse oximetry screening added a 46% sensitivity to the sole 
physical examination [26]. This compares with our findings that 
a good antenatal ultrasound examination and detailed physical 
examination can identify most of the heart diseases.
Bradshaw et al. in their study found that the average 
screening time for pulse oximetry was 3.5 min (0-35 min). They 
concluded that pulse oximetry can be implemented successfully 
in community hospitals without an excessive number of false 
positives or additional nursing staff [27].
Granelli et al. studied 10,000 normal newborns and 9 infants 
with left LHOD and found PPI value <0.70 giving an odds 
ratio for LHOD of 23.75 (95% CI 6.36-88.74). They concluded 
that PPI values lower than 0.70 may indicate illness and a 
value <0.50 (1st percentile) indicates definite underperfusion [11]. 
In our study, PPI in infants who passed the test was mean of 2.04 as 
compared to 0.65 in those who failed the test suggesting reduced 
systemic perfusion. Thus, PPI values might be a useful additional 
tool for early detection of LHOD. In our study, 2D ECHO could 
not be done on all neonates due to practical difficulties in doing, so 
however, all infants were followed up clinically through infancy.
CONCLUSION
Pulse oximeter screening for CCHD is a sensitive test with high 
specificity and negative predictive value. Incorporation of pulse 
oximetry to the routine assessment of the newborn infant can 
enhance detection of CCHD. Since not all CCHD are associated 
with hypoxemia, addition of PPI is a promising technique to 
detect impaired perfusion in the case of left LHODs and may 
cover the diagnostic gaps of this screening test.
Figure 2: Flow chart showing recruitment of cases
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